Diagnostics
saving valuable resources. Additionally, the early diagnosis of sepsis will enable earlier intervention before infections progress to more severe stages. Both outcomes directly address key healthcare challenges: reducing bed occupancy rates and minimising treatment costs. This dual benefit – improving patient outcomes while optimising resource utilisation – becomes particularly crucial when considering the projected impact of antimicrobial resistance on healthcare systems. If the AMR threat continues to grow, the pressure on hospital resources will be immense. Early and accurate intervention not only saves lives but also helps ensuring antibiotics are used only when truly necessary.
The future of acute care delivery As healthcare systems face mounting pressures on resources and capabilities, military medical innovations offer a promising pathway for addressing critical challenges in acute care delivery. The success of technologies like advanced infection diagnostics demonstrates the impact of adapting research from government labs for civilian healthcare applications. By continuing to identify and adapt suitable military innovations for civilian healthcare, there are widespread opportunities to develop more robust, efficient, and evidence-based approaches to care delivery.
CSJ
References 1. Matthews D. UK sets out major pivot to defence R&D [Internet]. Science Business. 2024. Available from: https://
sciencebusiness.net/news/dual-use/uk- sets-out-major-pivot-defence-rd
2. About the Playbook - Ploughshare, Innovation made real [Internet]. Ploughshare. 2024 [cited 3 Jan 2025]. Available from:
https://ploughshare.co.uk/ playbook/about-the-playbook/
3. Medtech Accelerator [Internet]. Medtech Accelerator. 2020. Available from: http://
www.medtechaccelerator.co.uk/
4. Presymptom Health. Breakthrough infection test designed to tackle antimicrobial resistance is on target for 2025 UK NHS availability after positive trial results [Internet]. 17 Dec 2024. Available from:
https://www.presymptom.com/ wp-content/uploads/2024/12/2412- Presymptom-trial-results_final-V02.pdf
5. Mata C. Faster diagnosis of infection & sepsis is a critical unmet need - Presymptom Health [Internet]. Presymptom Health. 2024 [cited 3 Jan 2025]. Available from: https://
www.presymptom.com/the-need/
CSJ advert Apr
24p.indd 1 03/04/2024 11:43 June 2025 I
www.clinicalservicesjournal.com 57 About the author
Dr. Mark Gostock, PhD, is VP Commercialisation at Ploughshare. His career has been focused on bringing cutting-edge technology to market, having spent the last decade within the technology transfer ecosystem. From classics to chemistry, engineering to astro-physics, his time in academic technology commercialisation brought success in out-licensing and spin-out creation across a diverse spectrum of sciences. Now, his focus with Ploughshare is overseeing the growth of the company’s life-sciences portfolio and successfully evolving early-stage healthcare and MedTech technologies into successful commercial ventures.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
